Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2024-02-28 Regulatory Filings
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal announcement of a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) between the company and POSCO. It details the contract value, duration, and counterparty. Since this is a specific regulatory disclosure regarding a material business contract that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2024-02-28 Korean
[기재정정]유상증자결정(종속회사의주요경영사항)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing titled '유상증자결정(종속회사의 주요경영사항)' (Decision on Paid-in Capital Increase - Major Management Matters of a Subsidiary) and includes a '정정신고(보고)' (Correction Report). It details the terms of a capital increase, including share issuance price, purpose of funds, and subscription methods. This falls under the category of announcements regarding capital structure changes and financing activities.
2024-02-23 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Aprogen) regarding a significant change in revenue or profit structure (30% or more). This is a standard preliminary earnings announcement required by the Korea Exchange (KRX) when financial results deviate significantly from the previous year. It provides key financial highlights (revenue, operating profit, net income) and explains the reasons for the change. It is not a full annual report, but rather an initial earnings release/disclosure of financial results. FY 2023
2024-02-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders (G-Base and related parties) in the company 'Aprogen'. This document type is specifically used to notify the market of significant shareholding changes and is classified as a Major Shareholding Notification.
2024-02-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. This type of filing is a standard regulatory requirement in South Korea for entities that acquire a significant stake (typically 5% or more) in a publicly traded company. It details the shareholding status, changes in holdings, and the purpose of the investment. Based on the provided filing categories, this fits the 'Major Shareholding Notification' (MRQ) classification.
2024-02-13 Korean
투자판단관련주요경영사항 (AP063(허셉틴 바이오시밀러) 임상3상 시험계획 승인(유럽 이외 기타 지역(인도)))
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) titled 'Investment Judgment Related Major Management Matters'. It details the approval of a Phase 3 clinical trial for a biosimilar drug (AP063) in India. This type of disclosure is a standard regulatory announcement for material corporate events in the Korean market, which falls under the 'Regulatory Filings' category as it does not fit into specific financial reporting or governance categories.
2024-02-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.